BIM
ACHV icon

BlackRock Investment Management’s Achieve Life Sciences ACHV Stock Holding History

BlackRock Investment Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2
Closed -$4K – 4032
2016
Q1 		$4K Hold
2
– – ﹤0.01% 3849
2015
Q4 		$6K Hold
2
– – ﹤0.01% 3813
2015
Q3 		$12K Hold
2
– – ﹤0.01% 3602
2015
Q2 		$9K Hold
2
– – ﹤0.01% 3758
2015
Q1 		$7K Hold
2
– – ﹤0.01% 3758
2014
Q4 		$8K Hold
2
– – ﹤0.01% 3744
2014
Q3 		$9K Buy
2
+1
+100% +$6.95K ﹤0.01% 3696
2014
Q2 		$9K Sell
1
-18
-95% -$221K ﹤0.01% 3659
2014
Q1 		$484K Hold
19
– – ﹤0.01% 2968
2013
Q4 		$345K Hold
19
– – ﹤0.01% 3119
2013
Q3 		$391K Buy
19
+1
+6% +$20.7K ﹤0.01% 3030
2013
Q2 		$392K Buy
+18
New +$403K ﹤0.01% 2972

Other funds holding ACHV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Investment Management's ACHV Position: Q2 2016 in Review

BlackRock Investment Management sold out of Achieve Life Sciences (ACHV) in Q2 2016, closing a stake of 2 shares — an estimated $4K sold.

BlackRock Investment Management first reported a position in ACHV in Q2 2013 and held it in 12 quarters. The position peaked at $484K in Q1 2014. 34 funds tracked by Wall St. Rank hold ACHV as of Q2 2016.

  • BlackRock Investment Management reported no remaining Achieve Life Sciences position as of Q2 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 2 Achieve Life Sciences shares in Q2 2016, an estimated $4K.
  • BlackRock Investment Management first reported a position in Achieve Life Sciences in Q2 2013 and held it in 12 quarters.
  • BlackRock Investment Management's Achieve Life Sciences position peaked at $484K in Q1 2014.
  • 34 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.